VISTA agonists for the treatment / prevention of ischemia and / or reperfusion injury
JP2023550310A5Inactive Publication Date: 2024-11-07TRUSTEES OF DARTMOUTH COLLEGE THE
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- JP2023528093
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2020-11-04
- Filing Date
- 2021-11-04
- Publication Date
- 2024-11-07
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 00000000_0000_ABST
Abstract
The present invention provides methods for treating and preventing damage caused by post-ischemic reperfusion by administering a VISTA agonist, optionally an agonistic anti-VISTA antibody or a VISTA fusion protein. The present invention specifically relates to the treatment and prevention of ischemia-reperfusion injury (IRI) and conditions associated with IRI, including myocardial infarction, cardiac surgery, stroke, solid organ transplant recipients, and postoperative acute kidney injury, by administering an agonistic anti-VISTA antibody.
Need to check novelty before this filing date? Find Prior Art
